Discover

News & Info

Quote List Quote List

Esperion Therap(ESPR.US)

Event Tracking

May8

Esperion Therapeutics released FY2026 Q1 earnings on May 8 Pre-Market (EST), actual revenue USD 80.1 M (forecast USD 84.52 M), actual EPS USD -0.1002 (forecast USD -0.03)

13:30

May5

BioPharma Credit PLC Announces Financing Allocation for Esperion Transaction

06:37

May4

Needham Analyst Downgrades Esperion to Hold

19:10

May1

Archimed to Take Over Esperion Therapeutics for up to $1.1 Billion

11:07

Apr30

Esperion Therapeutics to Release FY2026 Q1 Earnings on May 7, Pre-Market EST; Forecast Revenue USD 84.52M, EPS USD -0.03

00:49

Apr2

Esperion Completes Corstasis Acquisition

21:36

Schedules & Filings

Schedules

Filings

May8

Earning Release(EST)

FY2026 Q1 Earning Release (USD) Revenue 80.1 M, Net Income -25.2 M, EPS -0.1002

Mar10

Earning Release(EST)

FY2025 Q4 Earning Release (USD) Revenue 168.45 M, Net Income 61.83 M, EPS 0.2172

Nov6

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 87.31 M, Net Income -31.33 M, EPS -0.156

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More